Tag Archives: Japan

Japan drug price reforms risk hurting investment: Bristol-Myers CEO

TOKYO (Reuters) – Japan’s “overly restrictive” drug pricing policies risk diverting foreign direct investment to China and other markets, the chief executive of Bristol-Myers Squibb said on Thursday. The Japanese government made reforms in 2018 that change how its national health system pays for new and innovative drugs. But those changes are not science-based and… Read More »

Pfizer Japan drawn into valsartan recall after finding API from Mylan is tainted

The global recall of valsartan has now extended to Pfizer and to Japan, via Mylan and India. According to a translated copy of its announcement, Pfizer’s Tokyo-based Japanese subsidiary said it is recalling from the country five lots of its blood pressure combo drug Amubaro because its API contains impurities that are probable carcinogens. The recall began… Read More »